Browse our press releases on our Investors section, scroll down to read the latest from our teams around the world, and be inspired by our Podders.
PRESS RELEASES
Features
Insulet was named a 2024 Top Company by LinkedIn, ranking #14 out of 15 Midsize Companies in the U.S. We were recognized for our commitment to creating an exceptional workplace for professionals to grow their careers. LinkedIn Top Companies chooses the best workplaces based on career success, ability to advance, skills growth, and company stability, among other criteria.
Diabetes Technology and Therapeutics journal has published Omnipod® 5 real-world evidence to convey the impact that Omnipod 5 is having on people with diabetes to support automated insulin delivery (AID) as standard of care. The paper presents the largest published U.S. dataset in the current AID landscape and demonstrates positive clinical outcomes under real-world conditions across a diverse population.
Eric Benjamin, EVP, Chief Product and Customer Experience Officer, participated in a panel on diabetes care at South by Southwest (SXSW). Hosted by Amazon Pharmacy, a valued partner that makes Omnipod available to users with a prescription, the session discussed how to improve access to more affordable medications; the importance of improved technologies; and how inclusive, whole-person care is critical for managing, and even preventing, diabetes.
Podder Talk™ Blog
For Media Inquiries, please reach out to:
Angela Geryak Wiczek
Senior Director, Corporate Communications
[email protected]
For Investor Relations, please reach out to:
Deborah R. Gordon
Vice President, Investor Relations
[email protected]